Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

860 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Activation of AZIN1 RNA editing is a novel mechanism that promotes invasive potential of cancer-associated fibroblasts in colorectal cancer.
Takeda S, Shigeyasu K, Okugawa Y, Yoshida K, Mori Y, Yano S, Noma K, Umeda Y, Kondo Y, Kishimoto H, Teraishi F, Nagasaka T, Tazawa H, Kagawa S, Fujiwara T, Goel A. Takeda S, et al. Among authors: kishimoto h. Cancer Lett. 2019 Mar 1;444:127-135. doi: 10.1016/j.canlet.2018.12.009. Epub 2018 Dec 21. Cancer Lett. 2019. PMID: 30583079 Free PMC article.
RNA editing facilitates the enhanced production of neoantigens during the simultaneous administration of oxaliplatin and radiotherapy in colorectal cancer.
Komatsu Y, Shigeyasu K, Yano S, Takeda S, Takahashi K, Hata N, Umeda H, Yoshida K, Mori Y, Yasui K, Yoshida R, Kondo Y, Kishimoto H, Teraishi F, Umeda Y, Kagawa S, Michiue H, Tazawa H, Goel A, Fujiwara T. Komatsu Y, et al. Among authors: kishimoto h. Sci Rep. 2022 Aug 8;12(1):13540. doi: 10.1038/s41598-022-17773-0. Sci Rep. 2022. PMID: 35941214 Free PMC article.
Mechanism of resistance to trastuzumab and molecular sensitization via ADCC activation by exogenous expression of HER2-extracellular domain in human cancer cells.
Yoshida R, Tazawa H, Hashimoto Y, Yano S, Onishi T, Sasaki T, Shirakawa Y, Kishimoto H, Uno F, Nishizaki M, Kagawa S, Fujiwara T. Yoshida R, et al. Among authors: kishimoto h. Cancer Immunol Immunother. 2012 Nov;61(11):1905-16. doi: 10.1007/s00262-012-1249-x. Epub 2012 Mar 31. Cancer Immunol Immunother. 2012. PMID: 22465967 Free PMC article.
Targeted Photodynamic Virotherapy Armed with a Genetically Encoded Photosensitizer.
Takehara K, Tazawa H, Okada N, Hashimoto Y, Kikuchi S, Kuroda S, Kishimoto H, Shirakawa Y, Narii N, Mizuguchi H, Urata Y, Kagawa S, Fujiwara T. Takehara K, et al. Among authors: kishimoto h. Mol Cancer Ther. 2016 Jan;15(1):199-208. doi: 10.1158/1535-7163.MCT-15-0344. Epub 2015 Dec 1. Mol Cancer Ther. 2016. PMID: 26625896
860 results